View Document Preview and Link Document Date: 2015-03-25 12:51:00 Open Document File Size: 182,51 KB Share Result on Facebook
City Silver Spring / Tokyo / Washington / DC / Washington / D.C. / Carnegie Center Princeton / Center Princeton / / Company Otsuka Pharmaceutical Development & Commercialization Inc. / Plaintiff Otsuka America Pharmaceutical Inc. / COMPLAINT Plaintiffs Otsuka Pharmaceutical Co. Ltd. / Plaintiff Otsuka Pharmaceutical Development & Commercialization Inc. / Defendant FDA / Otsuka Pharmaceutical Co. Ltd. / Plaintiff Otsuka Pharmaceutical Co. Ltd. / Chiyoda / Otsuka America Pharmaceutical Inc. / / Country Japan / United States / / Event FDA Phase / Judicial Event / / Facility Center Princeton / / IndustryTerm abbreviated new drug applications / federal law / treatment of Tourette’s Disorder / treatment of rare diseases / / MedicalCondition rare diseases / Tourette’s Disorder / orphan disorder / diseases / disorders / / Organization U.S. Department of Health and Human Services / United States Government / Congress / U.S. Department of Justice / U.S. Food and Drug Administration / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Otsuka Pharmaceutical Co. / FDA’s Center for Drug Evaluation and Research / / Person Steven F. Osborne / Margaret Hamburg / Stephen Ostroff / Rod J. Rosenstein / Sylvia Mathews Burwell / Mary E. Kremzner / / Position Attorney / Secretary / Jr. Attorney General / Defendant HHS Secretary / Commissioner /Acting Commissioner / Commissioner / Acting Commissioner / / Product Abilify / such drug / Abilify® / brand drug / New Drug / Food / / ProgrammingLanguage DC / / ProvinceOrState New Jersey / Maryland / / URL http / SocialTag 
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND Otsuka Pharmaceutical Co., Ltd., 2-9 Kanda Tsukasa-machi Chiyoda-Ku Tokyo, [removed], Japan, and